Advertisement
Home Tags Weight Loss

Tag: Weight Loss

Novo Nordisk CEO Grilled by Congress Over Price of Ozempic

0
By Robin Foster HealthDay Reporter WEDNESDAY, Sept. 25, 2024 (HealthDay News) -- During a tense hearing before a Senate committee on Tuesday, Novo Nordisk CEO...

Cost Has Many Going Around Doctors to Get Weight-Loss Medications

0
By Dennis Thompson HealthDay Reporter WEDNESDAY, Sept. 18, 2024 (HealthDay News) -- Wegovy, Zepbound and other cutting-edge weight-loss drugs can be tough to get these...

Weight Reduction Varies for Patients Receiving Semaglutide, Liraglutide

0

Weight reduction at one year linked to medication active agent, dosage, treatment indication, persistence of coverage

At Least One in Five People Has Obesity in Each U.S. State

0

CDC data show that in 23 states, 35 percent or more of the population is now obese

Weight-Loss Drug Zepbound Now in Single-Dose Vials at Half the Price

0
By Ernie Mundell HealthDay Reporter TUESDAY, Aug. 27, 2024 (HealthDay News) -- Eli Lilly, maker of one of the blockbuster GLP-1 weight-loss drug Zepbound, says...

Only One-Quarter of Patients Still Taking Semaglutide for Weight Loss Two Years Later

0

Nonadherence likely owed to mix of side effects such as nausea and vomiting and out-of-pocket costs

Significantly More Weight Loss Seen With Tirzepatide Versus Semaglutide

0

Patients with overweight, obesity receiving tirzepatide significantly more likely to achieve ≥5, ≥10, and ≥15 percent weight loss

WHO, Lilly Issue Warnings About Fake Weight-Loss Drugs

0
By Robin Foster HealthDay Reporter FRIDAY, June 21, 2024 (HealthDay News) -- Both the World Health Organization and Eli Lilly warned Thursday that consumers should...

Meal Replacement + Financial Incentives Beneficial for Teens With Obesity

0

For teens with severe obesity, meal replacement therapy plus financial incentives result in greater reduction in BMI, fat mass

Insulin-Treated T2D Patients Unwilling to Participate in Intensive Lifestyle Intervention

0

Adults with insulin-treated T2D unwilling to participate in lifestyle intervention mainly because intervention is too intense